StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.95+0.06 (+7.26%)

Close on Nov 18, 2026Market cap $94.80MP/E –Yield –

Stereotaxis pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Stereotaxis's pe ratio was 847.5× on Apr 30, 2019.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Apr 30, 2019847.5×+772.4
2018Jan 31, 201875.1×−4.9
2017Dec 29, 201780.0×–

More Stereotaxis figures

See a number that looks wrong?